How to buy Amarin shares | AMRN historical share price and analysis

How to buy Amarin shares

Own Amarin shares in just a few minutes.

Updated

Fact checked

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Amarin Corporation plc is a biotechnology business with stocks listed in the US. Amarin shares (AMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Here's how to invest if you're based in Australia.

How to buy shares in Amarin

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Amarin. Find the share by name or ticker symbol: AMRN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Amarin reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Amarin, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Amarin. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

Amarin share price

Use our graph to track the performance of AMRN stocks over time.

Amarin shares at a glance

Information last updated 2021-03-03.
52-week rangeUS$3.36 - US$16.24
50-day moving average US$7.28
200-day moving average US$5.5643
Target priceUS$10.64
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) US$-0.266

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data updated regularly
Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro Share Trading (US stocks)
USD 0
USD 10 per month if there’s been no login for 12 months
0.50%
Forex, CFDs, US shares
Zero brokerage share trading on US stocks with trades as low as $50.
Note: This broker offers CFDs which are volatile investment products and most clients lose money trading CFDs with this provider.
Join the world’s biggest social trading network when you trade stocks, commodities and forex from the one account.
CMC Markets Stockbroking
USD 0
No
0.60%
ASX shares, Global shares, Forex, CFDs, Options trading, mFunds, ETFs, Warrants
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, managed funds, forex, commodities and cryptocurrencies, plus access up to 15 major global and Australian stock exchanges.
IG Share Trading
Finder Award
IG Share Trading
USD 0
AUD 50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares, Forex, CFDs, Margin trading
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Note: $10,000 deposit required to open account.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, forex and CFDs, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
USD 9.9
No
0.75%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading
High quality, low-cost brokerage on global share trading.
Access up to 19,000 global stocks on 36 of the world’s major stock exchanges and enjoy some of the most competitive FX rates on the the market when you trade with Saxo Capital Markets.
loading

Compare up to 4 providers

Is it a good time to buy Amarin stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Amarin financials

Revenue TTM US$614.1 million
Gross profit TTM US$482.6 million
Return on assets TTM -1.33%
Return on equity TTM -2.91%
Profit margin -2.93%
Book value 1.599
Market capitalisation US$2.4 billion

TTM: trailing 12 months

Shorting Amarin shares

There are currently 20.1 million Amarin shares held short by investors – that's known as Amarin's "short interest". This figure is 0.4% down from 20.2 million last month.

There are a few different ways that this level of interest in shorting Amarin shares can be evaluated.

Amarin's "short interest ratio" (SIR)

Amarin's "short interest ratio" (SIR) is the quantity of Amarin shares currently shorted divided by the average quantity of Amarin shares traded daily (recently around 8.2 million). Amarin's SIR currently stands at 2.45. In other words for every 100,000 Amarin shares traded daily on the market, roughly 2450 shares are currently held short.

However Amarin's short interest can also be evaluated against the total number of Amarin shares, or, against the total number of tradable Amarin shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amarin's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Amarin shares in existence, roughly 50 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Amarin shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Amarin.

Find out more about how you can short Amarin stock.

Amarin share dividends

We're not expecting Amarin to pay a dividend over the next 12 months.

Have Amarin's shares ever split?

Amarin's shares were split on a 1:10 basis on 18 January 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amarin shares which in turn could have impacted Amarin's share price.

Amarin share price volatility

Over the last 12 months, Amarin's shares have ranged in value from as little as US$3.36 up to US$16.24. A popular way to gauge a stock's volatility is its "beta".

AMRN.US volatility(beta: 2.38)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin's is 2.3778. This would suggest that Amarin's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Amarin overview

Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing REDUCE-IT for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site